Application of activity-based probes to the study of enzymes involved in cancer progression.
暂无分享,去创建一个
[1] H. Ploegh,et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] Ralph Weissleder,et al. Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.
[3] Kinneret Keren,et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.
[4] Bonnie F. Sloane,et al. Functional imaging of tumor proteolysis. , 2006, Annual review of pharmacology and toxicology.
[5] D. Filippov,et al. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. , 2006, Chemistry & biology.
[6] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[7] A. Saghatelian,et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. , 2006, Chemistry & biology.
[8] M. Bogyo,et al. Tagging and detection strategies for activity-based proteomics. , 2007, Current opinion in chemical biology.
[9] M. Bogyo,et al. Enzyme activity--it's all about image. , 2004, Trends in cell biology.
[10] O. Vasiljeva,et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.
[11] Anna E Speers,et al. Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.
[12] G. Winberg,et al. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines , 2006, Molecular carcinogenesis.
[13] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[14] Nasreen S Jessani,et al. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] Gavin MacBeath,et al. Protein microarrays and proteomics , 2002, Nature Genetics.
[16] Nasreen S Jessani,et al. Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[18] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[19] A. Saghatelian,et al. Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling , 2005, Nature Biotechnology.
[20] M. Bogyo,et al. Proteomics meets microbiology: technical advances in the global mapping of protein expression and function , 2005, Cellular microbiology.
[21] Dale L Boger,et al. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.
[22] M. Bogyo,et al. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. , 2006, Molecular cell.
[23] D. Ferris,et al. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. , 2005, Chemistry & biology.
[24] R. Fridman,et al. Extracellular proteases as targets for treatment of cancer metastases. , 2004, Chemical Society reviews.
[25] B. Cravatt,et al. Activity-based probes for proteomic profiling of histone deacetylase complexes , 2007, Proceedings of the National Academy of Sciences.
[26] D. Hanahan,et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.
[27] J. Quigley,et al. Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.
[28] K. Anderson,et al. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib , 2005, Nature Methods.
[29] Sherry L. Niessen,et al. Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation* , 2006, Journal of Biological Chemistry.
[30] E. Diamandis,et al. The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.
[31] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[32] A. Hermetter,et al. Activity-based proteomics: enzymatic activity profiling in complex proteomes , 2006, Amino Acids.
[33] Matthew Bogyo,et al. Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. , 2007, Current pharmaceutical design.
[34] H. Ovaa. Active-site directed probes to report enzymatic action in the ubiquitin proteasome system , 2007, Nature Reviews Cancer.
[35] John R Yates,et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Cravatt,et al. Trifunctional Chemical Probes for the Consolidated Detection and Identification of Enzyme Activities from Complex Proteomes*S , 2002, Molecular & Cellular Proteomics.
[37] B. Cravatt,et al. Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.
[38] H. Ovaa,et al. Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells , 2007, Leukemia.
[39] Sherry L. Niessen,et al. Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.
[40] M. Bogyo,et al. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases. , 2007, Chemistry & biology.
[41] B. Cravatt,et al. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype , 2002, Nature Biotechnology.
[42] A. Burlingame,et al. Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.
[43] Bonnie F. Sloane,et al. Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.
[44] K. Anderson,et al. Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells. , 2005, Cancer research.
[45] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[46] D. Berger,et al. Role of Proteases in Pancreatic Carcinoma , 2005, World Journal of Surgery.
[47] Nasreen S Jessani,et al. A streamlined platform for high-content functional proteomics of primary human specimens , 2005, Nature Methods.